Nitric Acid → 3,3,7,7-Tetranitro-1,5-dinitroso-1,5-diazocane
Reaktionsgleichung
[N+:1]([C:4]1([N+:20]([O-:22])=[O:21])[CH2:11][NH:10][CH2:9][C:8]([N+:15]([O-:17])=[O:16])([N+:12]([O-:14])=[O:13])[CH2:7][N:6]([N:18]=[O:19])[CH2:5]1)([O-:3])=[O:2].[N+:23]([O-])(O)=[O:24]>>[N+:20]([C:4]1([N+:1]([O-:3])=[O:2])[CH2:11][N:10]([N:23]=[O:24])[CH2:9][C:8]([N+:15]([O-:17])=[O:16])([N+:12]([O-:14])=[O:13])[CH2:7][N:6]([N:18]=[O:19])[CH2:5]1)([O-:22])=[O:21]Komponenten
3
Versuchsvorschrift
nitrosating the 3,3,7,7-tetranitro-1-nitrosoperhydro-1,5-diazocine in from about 55 to about 70 percent nitric acid to form 3,3,7,7-tetranitro-1,5-dinitrosoperhydro-1,5-diazocine product; and
Quellen und Nachweise
- ORD-Eintrag
- ord-446b9bcd122c47f5af16e6bbd83961b7
- Quelldatensatz
- uspto-grants-1984_06
- Patentnummer
- US04452739